| 1 |
Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophrenia |
|
2010 |
-- |
|
| 2 |
Decreased frontal serotonin2A receptor binding in antipsychotic-naive patients with first-episode schizophrenia |
|
2010 |
-- |
|
| 3 |
Cortical and subcortical 5-HT2A receptor binding in neuroleptic-naive
first-episode schizophrenic patients. |
David Erritzoe, Hans Rasmussen, Klaus T Kristiansen, Vibe G Frokjaer, Steven Haugbol, Lars Pinborg, William Baaré, Claus Svarer, Jacob Madsen, Henrik Lublin, Gitte M Knudsen, Birte Y Glenthoj |
2008 |
-- |
|
| 4 |
Divergent effects of increased serotonergic activity on psychophysiological
parameters of human attention. |
Bob Oranje, Kristian Jensen, Malene Wienberg, Birte Y Glenthøj |
2008 |
-- |
|
| 5 |
The effects of increased serotonergic activity on human sensory gating
and its neural generators. |
Kristian S Jensen, Bob Oranje, Malene Wienberg, Birte Y Glenthøj |
2008 |
-- |
|
| 6 |
Evaluation of a neurodevelopmental model of schizophrenia--early
postnatal PCP treatment in attentional set-shifting. |
Brian Villumsen Broberg, Rebecca Dias, Birte Yding Glenthøj, Christina Kurre Olsen |
2008 |
-- |
|
| 7 |
Decreased gene expression of neuropeptide Y and its receptors in
hippocampal regions during ethanol withdrawal in rats. |
Janne D Olling, Jakob Ulrichsen, Steven Haugbøl, Birte Glenthøj, Ralf Hemmingsen, David P D Woldbye |
2007 |
-- |
|
| 8 |
The effects of increased central serotonergic activity on prepulse
inhibition and habituation of the human startle response. |
Kristian S Jensen, Bob Oranje, Malene Wienberg, Birte Y Glenthøj |
2007 |
-- |
|
| 9 |
The effects of imipramine on P50 suppression, prepulse inhibition
and habituation of the startle response in humans. |
Trine-Bjoerg Hammer, Bob Oranje, Birte Y Glenthoj |
2007 |
-- |
|
| 10 |
Effects of Donepezil Adjunctive Treatment to Ziprasidone on Cognitive
Deficits in Schizophrenia: A Double-blind, Placebo-Controlled Study. |
Birgitte Fagerlund, Bettina Søholm, Anders Fink-Jensen, Henrik Lublin, Birte Glenthøj |
2007 |
-- |
|
| 11 |
Divergent effects of increased serotonergic activity on psychophysiological
parameters of human attention. |
Bob Oranje, Kristian Jensen, Malene Wienberg, Birte Y Glenthøj |
2007 |
-- |
|
| 12 |
Basal ganglia volumes in drug-naive first-episode schizophrenia patients
before and after short-term treatment with either a typical or an
atypical antipsychotic drug. |
Andreas Glenthoj, Birte Y Glenthoj, Torben Mackeprang, Anne K Pagsberg, Ralf P Hemmingsen, Terry L Jernigan, William F C Baaré |
2007 |
-- |
|
| 13 |
[(123)I]Epidepride binding to cerebellar dopamine D(2)/D(3) receptors
is displaceable: Implications for the use of cerebellum as a reference
region. |
Lars H Pinborg, Charlotte Videbaek, Morten Ziebell, Torben Mackeprang, Lars Friberg, Hans Rasmussen, Gitte M Knudsen, Birte Y Glenthoj |
2007 |
-- |
|
| 14 |
The effects of increased serotonergic activity on human sensory gating
and its neural generators. |
Kristian Jensen, Bob Oranje, Malene Wienberg, Birte Glenthøj |
2007 |
-- |
|
| 15 |
No effects of l-dopa and bromocriptine on psychophysiological parameters
of human selective attention. |
B. Oranje, C. C. Gispen-de Wied, H. G M Westenberg, C. Kemner, M. N. Verbaten, R. S. Kahn |
2006 |
-- |
|
| 16 |
Association between the CCR5 32-bp deletion allele and late onset
of schizophrenia. |
Henrik Berg Rasmussen, Sally Timm, August G Wang, Karen Søeby, Henrik Lublin, Mogens Fenger, Ralf Hemmingsen, Thomas Werge |
2006 |
-- |
|
| 17 |
A neural cell adhesion molecule-derived fibroblast growth factor
receptor agonist, the FGL-peptide, promotes early postnatal sensorimotor
development and enhances social memory retention. |
T. Secher, V. Novitskaia, V. Berezin, E. Bock, B. Glenthøj, B. Klementiev |
2006 |
-- |
|
| 18 |
Prepulse inhibition and P50 suppression: commonalities and dissociations. |
Bob Oranje, Mark A Geyer, Koen B E Bocker, J. Leon Kenemans, Marinus N Verbaten |
2006 |
-- |
|
| 19 |
The influence of amphetamine on language activation: an fMRI study. |
Iris E C Sommer, Bob Oranje, Nick F Ramsey, Floris A Klerk, René C W Mandl, Herman G M Westenberg, René S Kahn |
2006 |
-- |
|
| 20 |
Frontal dopamine D(2/3) receptor binding in drug-naive first-episode
schizophrenic patients correlates with positive psychotic symptoms
and gender. |
Birte Y Glenthoj, Torben Mackeprang, Claus Svarer, Hans Rasmussen, Lars H Pinborg, Lars Friberg, William Baaré, Ralf Hemmingsen, Charlotte Videbaek |
2006 |
-- |
|
| 21 |
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines
for biological treatment of schizophrenia, part 2: long-term treatment
of schizophrenia. |
Peter Falkai, Thomas Wobrock, Jeffrey Lieberman, Birte Glenthoj, Wagner F Gattaz, Hans-Jürgen Möller, on Treatment Guidelines for Schizophrenia, W. F. S. B. P. Ta |
2006 |
-- |
|
| 22 |
Current therapy issues and unmet clinical needs in the treatment
of schizophrenia: a review of the new generation antipsychotics. |
Henrik Lublin, Jonas Eberhard, Sten Levander |
2005 |
-- |
|
| 23 |
Cognitive deficits caused by late gestational disruption of neurogenesis
in rats: a preclinical model of schizophrenia. |
Peter Flagstad, Birte Y Glenthøj, Michael Didriksen |
2005 |
-- |
|
| 24 |
Drug therapy of dementia in elderly patients. A review. |
Carsten Emil Olsen, Henrik Day Poulsen, Henrik K F Lublin |
2005 |
-- |
|
| 25 |
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines
for biological treatment of schizophrenia, Part 1: acute treatment
of schizophrenia. |
Peter Falkai, Thomas Wobrock, Jeffrey Lieberman, Birte Glenthoj, Wagner F Gattaz, Hans-Jürgen Möller, on Treatment Guidelines for Schizophrenia, W. F. S. B. P. Ta |
2005 |
-- |
|
